At close: 3:30:19 PM GMT+9
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 4 | 6 |
| Avg. Estimate | 0 | 0 | 6,454.17 | 9,850 |
| Low Estimate | 0 | 0 | 5,980.67 | 9,437 |
| High Estimate | 0 | 0 | 7,467 | 11,478 |
| Year Ago EPS | -- | -- | 10,656 | 6,454.17 |
Revenue Estimate
| Currency in KRW | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 2 | 5 | 5 |
| Avg. Estimate | 362.6B | 332.6B | 1.42T | 1.53T |
| Low Estimate | 361B | 328.3B | 1.42T | 1.52T |
| High Estimate | 373.1B | 336.9B | 1.43T | 1.54T |
| Year Ago Sales | 319.6B | 296.59B | 1.38T | 1.42T |
| Sales Growth (year/est) | 13.45% | 12.14% | 3.03% | 8.05% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 6,454.17 | 9,850 |
| 7 Days Ago | 0 | 0 | 6,448.17 | 10,056.5 |
| 30 Days Ago | 0 | 0 | 6,448.17 | 10,056.5 |
| 60 Days Ago | 0 | 0 | 6,434 | 9,947 |
| 90 Days Ago | 0 | 0 | 6,551.17 | 9,947 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 3 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 069620.KS | -- | -- | -39.43% | 52.61% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Related Tickers
128940.KS Hanmi Pharm. Co., Ltd.
278,500.00
-0.71%
003090.KS Daewoong Co., Ltd.
21,200.00
-1.85%
BSPM Biostar Pharmaceuticals, Inc.
0.0001
-90.00%
006280.KS GC Biopharma Corp.
172,400.00
-3.96%
000100.KS Yuhan Corporation
118,300.00
-1.00%
009420.KS Hanall Biopharma Co., Ltd.
38,500.00
-0.39%
TKPHF Takeda Pharmaceutical Company Limited
26.75
+3.24%
ESAIY Eisai Co., Ltd.
6.74
-0.44%
VDRM ViaDerma, Inc.
0.0072
-2.70%
CBDL CBD Life Sciences Inc.
0.0004
0.00%